PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Fortitech, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Fortitech Asia Pacific Targets Bone Brain and Gut Health at FIA 2006 - To prove that everyday food and beverage products can deliver optimal nutrition, Fortitech Asia Pacific displayed several new fortification initiatives at Food Ingredients Asia in Bangkok, Thailand
Fortitech Asia Pacific Targets Bone Brain and Gut Health at FIA 2006

 

NewswireToday - /newswire/ - Bangkok, Thailand, 2006/09/20 - To prove that everyday food and beverage products can deliver optimal nutrition, Fortitech Asia Pacific displayed several new fortification initiatives at Food Ingredients Asia in Bangkok, Thailand.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

With a focus on gut, bone and brain health, these fortified applications are a perfect option for improving and/or maintaining wellness for older or aging generations.

Fortitech Asia Pacific has taken a strategic and scientific approach to fortifying these products. Our scientists have successfully overcome the major issues that typically show up in the formulation process including stability, taste and texture to make top-quality, marketable functional food samples.

The team displayed a prebiotic biscuit with a nutritional profile that focuses on gut health. This application contains fiber which is associated with significantly reducing risks of cardiovascular disease and cancer; selenium and zinc, both powerful antioxidants; calcium for bone health, plus inulin for gut-health.

A 3-in-1 vitamin-mineral instant cereal which supplies brain health benefits was presented to visitors. The premix used in this application was packed with vitamins B2, B6, C and E, plus thiamine for extra energy. Other added nutrients include chromium, zinc, magnesium and choline.

Beverages are the most popular and fastest-growing functional food sectors in the nutrition industry. Fortitech Asia Pacific supported that trend by formulating a bone-healthy soymilk. A great option for kids or older adults, this application contains a vitamin D3 and 120 mg of calcium per 100 ml serving.

Also proving innovation and health-focus was a fortified gummy bear - a fun and unique way to get a solid source of nutrition. Each bear contains 50% EU RDI of vitamins A, B6, B12, C, E and D3, plus folic acid biotin and niacinamide.

About Fortitech Asia Pacific
Fortitech Asia Pacific Sdn Bhd (fortitech.com) is part of the global network of manufacturing and distribution companies of Fortitech, Inc., the world leader in the development of custom nutrient premixes for the food, beverage and pharmaceutical industries. Located in Kuala Lumpur, Malaysia, the company is exclusively dedicated to the manufacture of nutrient premixes. Fortitech Asia Pacific is ISO 9001:2000 certified and HACCP, Halal and PNDC certified. Fortitech Asia Pacific also meets requirements for Allergen Monitoring program standards. FortiSource™ - the ultimate fortification destination.

Not just premixes...Strategic Nutrition.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Fortitech, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Fortitech Asia Pacific Targets Bone Brain and Gut Health at FIA 2006

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mark Fanion 
518-372-5155 info[.]fortitech.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Fortitech, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Fortitech, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  1Click Games

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)